These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6280730)

  • 61. Characterization of a cAMP/cGMP phosphodiesterase sensitive to calmodulin [proceedings].
    Ilien B; Landry Y
    Arch Int Physiol Biochim; 1980 Feb; 88(1):B32-B33. PubMed ID: 6155846
    [No Abstract]   [Full Text] [Related]  

  • 62. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells.
    Souness JE; Diocee BK; Martin W; Moodie SA
    Biochem J; 1990 Feb; 266(1):127-32. PubMed ID: 2155604
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Purification of two calcium/calmodulin-dependent forms of cyclic nucleotide phosphodiesterase by using conformation-specific monoclonal antibody chromatography.
    Hansen RS; Beavo JA
    Proc Natl Acad Sci U S A; 1982 May; 79(9):2788-92. PubMed ID: 6283544
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Inhibition of calmodulin-stimulated cyclic nucleotide phosphodiesterase by the insecticide DDT.
    Hagmann J
    FEBS Lett; 1982 Jun; 143(1):52-4. PubMed ID: 6288452
    [No Abstract]   [Full Text] [Related]  

  • 65. Particulate cyclic 3',5'-nucleotide phosphodiesterase and calmodulin of cardiac muscle.
    Ahluwalia G; Rhoads AR; Lulla M
    Int J Biochem; 1984; 16(5):483-8. PubMed ID: 6327416
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Do conventional plasma cyclic nucleotide phosphodiesterase inhibitors really work in all situations?
    Wood PJ; Pao G; Ross G; Smith C
    Clin Chim Acta; 1981 Sep; 115(3):405-8. PubMed ID: 6271425
    [No Abstract]   [Full Text] [Related]  

  • 67. Calcium: calmodulin and cancer.
    Criss WE; Kakiuchi S
    Fed Proc; 1982 May; 41(7):2289-91. PubMed ID: 6281083
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Differential effects of various phosphodiesterase inhibitors, pyrimidine and purine compounds, and inorganic phosphates on cyclic CMP, cyclic AMP and cyclic GMP phosphodiesterases.
    Helfman DM; Kuo JF
    Biochem Pharmacol; 1982 Jan; 31(1):43-7. PubMed ID: 6277336
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Selective inhibition by NPT 15392 of lymphocyte cyclic GMP phosphodiesterase.
    Coffey RG; Hartley L; Polson JB; Krzanowski JJ; Hadden JW
    Biochem Pharmacol; 1984 Nov; 33(21):3411-7. PubMed ID: 6093811
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Irreversible inhibition of calmodulin-sensitive cyclic nucleotide phosphodiesterase.
    Sullivan TA; Duemler BH; Kuttesch NJ; Keravis TM; Wells JN
    J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(5):355-64. PubMed ID: 2442214
    [TBL] [Abstract][Full Text] [Related]  

  • 71. KS-505a, a novel inhibitor of bovine brain Ca2+ and calmodulin-dependent cyclic-nucleotide phosphodiesterase from Streptomyces argenteolus.
    Nakanishi S; Osawa K; Saito Y; Kawamoto I; Kuroda K; Kase H
    J Antibiot (Tokyo); 1992 Mar; 45(3):341-7. PubMed ID: 1374373
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Differential inhibition of calmodulin-sensitive phosphodiesterase and Ca++-adenosine triphosphatase by chlorpromazine-linked calmodulin.
    Prozialeck WC; Wallace TL; Weiss B
    J Pharmacol Exp Ther; 1987 Oct; 243(1):171-9. PubMed ID: 2822896
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Selective inhibitor of platelet cyclic adenosine monophosphate phosphodiesterase, cilostamide, inhibits platelet aggregation.
    Hidaka H; Hayashi H; Kohri H; Kimura Y; Hosokawa T; Igawa T; Saitoh Y
    J Pharmacol Exp Ther; 1979 Oct; 211(1):26-30. PubMed ID: 226672
    [No Abstract]   [Full Text] [Related]  

  • 74. PDE inhibitors: a new approach to treat metabolic syndrome?
    Lugnier C
    Curr Opin Pharmacol; 2011 Dec; 11(6):698-706. PubMed ID: 22018840
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Parathyroid hormone induces a calmodulin-dependent alteration in phosphodiesterase activity of rat kidney in vivo.
    Marcus R; Grant BF
    Endocrinology; 1983 Mar; 112(3):1065-9. PubMed ID: 6295744
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Two forms of cyclic nucleotide phosphodiesterase and Ca-dependent protein regulator from rabbit skeletal muscles].
    Lazarevich VG; Men'shikov MIu; Tkachuk VA
    Biokhimiia; 1979 Oct; 44(10):1842-51. PubMed ID: 228768
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cyclic AMP phosphodiesterase and cyclic GMP phosphodiesterase activities of rat mammary tissue.
    Mullaney I; Clegg RA
    Biochem J; 1984 May; 219(3):801-9. PubMed ID: 6331397
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Selective inhibitors of calmodulin-dependent phosphodiesterase and other enzymes.
    Hidaka H; Inagaki M; Nishikawa M; Tanaka T
    Methods Enzymol; 1988; 159():652-60. PubMed ID: 2842626
    [No Abstract]   [Full Text] [Related]  

  • 79. Influence of tricyclic antidepressants on the adenylate cyclase-phosphodiesterase system in the rat cortex.
    Palmer GC
    Neuropharmacology; 1976 Jan; 15(1):1-7. PubMed ID: 176608
    [No Abstract]   [Full Text] [Related]  

  • 80. Polymyxin B is a selective and potent antagonist of calmodulin.
    Hegemann L; van Rooijen LA; Traber J; Schmidt BH
    Eur J Pharmacol; 1991 May; 207(1):17-22. PubMed ID: 1915592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.